2026 Q1 Portfolio Activity
In 2026 Q1, Nantahala Capital Management, LLC maintained a portfolio of 176 distinct positions. The most significant new addition was JANUX THERAPEUTICS INC, now representing 0.41% of the total fund value. They heavily accumulated shares in ISHARES TR, increasing the position by 1649.8%. The fund also reduced its exposure to ISHARES TR by 24.1%.
Position History
hover any row below to update
Loading…
Total Positions
176
Quarter
2026 Q1
Top Holding
IWM (18.7%)
Top 10 Concentration
40.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 176
Nantahala Capital Management, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
IWM
PUT
ISHARES TR
|
PUT Option | 18.72% | 21.97% |
#1
Prev: #1
|
6.0 |
—
|
-650,000 | -24.1% |
P
S
|
2,050,000 | $508,400,000 | 2012 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HLF
CALL
HERBALIFE LTD
|
CALL Option | 3.03% | 3.32% |
#2
1
Prev: #3
|
2.7 |
—
|
-2,200,000 | -28.2% |
P
S
|
5,600,000 | $82,432,000 | 2012 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PTON
CALL
PELOTON INTERAC...
|
CALL Option | 2.83% | 1.32% |
#3
13
Prev: #16
|
5.1 |
—
|
11,438,900 | 176.0% |
P
S
|
17,938,900 | $76,957,881 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TBBK
BANCORP INC DEL
|
Financial Services | 2.73% | 2.39% |
#4
1
Prev: #5
|
4.1 |
—
|
308,771 | 28.8% |
P
S
|
1,380,456 | $74,171,901 | 2014 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VTRS
CALL
VIATRIS INC
|
CALL Option | 2.49% | 2.06% |
#5
3
Prev: #8
|
2.5 |
—
|
no change | no change |
P
S
|
5,000,000 | $67,550,000 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EW
PUT
EDWARDS LIFESCI...
|
PUT Option | 2.36% | 5.07% |
#6
4
Prev: #2
|
0.9 |
—
|
-1,000,000 | -55.6% |
P
S
|
800,000 | $64,064,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HGV
HILTON GRAND VA...
|
Consumer Cyclical | 2.18% | 2.31% |
#7
Prev: #7
|
1.4 |
—
|
-47,966 | -3.1% |
P
S
|
1,513,656 | $59,214,223 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 2.15% | 2.01% |
#8
1
Prev: #9
|
3.4 |
—
|
430,122 | 32.7% |
P
S
|
1,744,124 | $58,393,272 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BVS
BIOVENTUS INC
|
Healthcare | 2.06% | 1.49% |
#9
5
Prev: #14
|
1.3 |
—
|
75,000 | 1.2% |
P
S
|
6,122,403 | $55,897,539 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PTON
PELOTON INTERAC...
|
Consumer Cyclical | 1.90% | 1.21% |
#10
9
Prev: #19
|
3.8 |
—
|
6,067,324 | 102.3% |
P
S
|
12,000,000 | $51,480,000 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 1.74% | 2.38% |
#11
5
Prev: #6
|
1.2 |
—
|
-154,733 | -15.7% |
P
S
|
832,956 | $47,295,242 | 2018 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TEVA
CALL
TEVA PHARMACEUT...
|
CALL Option | 1.66% | 2.58% |
#12
8
Prev: #4
|
0.7 |
—
|
-1,000,000 | -40.0% |
P
S
|
1,500,000 | $45,180,000 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
QURE
CALL
UNIQURE NV
|
CALL Option | 1.56% | — |
#13
Prev: #—
|
4.1 |
—
|
2,600,000 | — |
NEW
|
2,600,000 | $42,510,000 | 2016 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HGV
CALL
HILTON GRAND VA...
|
CALL Option | 1.55% | 1.59% |
#14
1
Prev: #13
|
1.6 |
—
|
no change | no change |
P
S
|
1,075,000 | $42,054,000 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SVRA
SAVARA INC
|
Healthcare | 1.48% | 1.46% |
#15
Prev: #15
|
1.6 |
—
|
no change | no change |
P
S
|
7,344,783 | $40,102,515 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 1.41% | 1.61% |
#16
5
Prev: #11
|
0.6 |
—
|
-100,000 | -25.0% |
P
S
|
300,000 | $38,319,000 | 2014 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XTNT
XTANT MED HLDGS...
|
Healthcare | 1.40% | 1.77% |
#17
7
Prev: #10
|
1.6 |
—
|
no change | no change |
P
S
|
68,394,000 | $38,163,852 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GOGO
GOGO INC
|
Communication Services | 1.31% | 1.05% |
#18
2
Prev: #20
|
3.0 |
—
|
2,089,387 | 30.8% |
P
S
|
8,882,036 | $35,705,785 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AMRX
AMNEAL PHARMACE...
|
Healthcare | 1.30% | 1.02% |
#19
4
Prev: #23
|
2.5 |
—
|
396,592 | 16.2% |
P
S
|
2,844,108 | $35,352,262 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
REGN
CALL
REGENERON PHARM...
|
CALL Option | 1.14% | 1.02% |
#20
2
Prev: #22
|
1.5 |
—
|
no change | no change |
P
S
|
40,000 | $30,905,600 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 1.13% | 0.42% |
#21
38
Prev: #59
|
3.5 |
—
|
3,000,000 | 118.5% |
P
S
|
5,530,910 | $30,696,550 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ETON
ETON PHARMACEUT...
|
Healthcare | 1.07% | 0.66% |
#22
10
Prev: #32
|
1.4 |
—
|
no change | no change |
P
S
|
1,175,951 | $29,022,471 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 0.96% | 1.28% |
#23
6
Prev: #17
|
2.4 |
—
|
556,208 | 9.6% |
P
S
|
6,376,857 | $26,208,882 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 0.96% | 1.05% |
#24
3
Prev: #21
|
0.4 |
—
|
-2,322,181 | -65.0% |
P
S
|
1,250,452 | $26,159,456 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 0.96% | 0.50% |
#25
25
Prev: #50
|
3.4 |
—
|
377,894 | 56.0% |
P
S
|
1,052,894 | $25,964,366 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
CALL
SOLENO THERAPEU...
|
CALL Option | 0.92% | 0.77% |
#26
3
Prev: #29
|
2.9 |
—
|
248,000 | 49.4% |
P
S
|
750,000 | $25,110,000 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FOXF
FOX FACTORY HLD...
|
Consumer Cyclical | 0.90% | 1.24% |
#27
9
Prev: #18
|
0.4 |
—
|
-700,000 | -32.0% |
P
S
|
1,488,300 | $24,497,418 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.89% | 0.14% |
#28
79
Prev: #107
|
3.4 |
—
|
782,196 | 690.5% |
P
S
|
895,481 | $24,258,580 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZVRA
ZEVRA THERAPEUT...
|
Healthcare | 0.87% | 0.52% |
#29
17
Prev: #46
|
2.8 |
—
|
750,000 | 42.3% |
P
S
|
2,521,936 | $23,504,444 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.86% | 1.61% |
#30
18
Prev: #12
|
0.3 |
—
|
-1,243,306 | -29.0% |
P
S
|
3,050,040 | $23,393,807 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FOSL
FOSSIL GROUP IN...
|
Consumer Cyclical | 0.86% | 0.63% |
#31
5
Prev: #36
|
2.3 |
—
|
339,665 | 6.7% |
P
S
|
5,404,024 | $23,291,343 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RMBL
RIDENOW GROUP I...
|
Unknown | 0.85% | 0.60% |
#32
7
Prev: #39
|
1.3 |
—
|
no change | no change |
P
S
|
3,272,845 | $23,106,286 | 2018 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABEO
ABEONA THERAPEU...
|
Healthcare | 0.83% | 0.86% |
#33
7
Prev: #26
|
0.8 |
—
|
50,000 | 1.0% |
P
S
|
5,013,052 | $22,458,473 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CWH
CAMPING WORLD H...
|
Consumer Cyclical | 0.82% | 0.34% |
#34
33
Prev: #67
|
3.3 |
—
|
2,200,732 | 207.9% |
P
S
|
3,259,274 | $22,260,841 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 0.77% | 0.64% |
#35
Prev: #35
|
0.8 |
—
|
122,000 | 2.2% |
P
S
|
5,597,433 | $20,990,374 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TITN
TITAN MACHY INC
|
Industrials | 0.77% | 0.61% |
#36
2
Prev: #38
|
0.8 |
—
|
34,000 | 2.8% |
P
S
|
1,254,520 | $20,975,574 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HLF
HERBALIFE LTD
|
Consumer Defensive | 0.73% | 0.38% |
#37
26
Prev: #63
|
3.3 |
—
|
471,796 | 53.5% |
P
S
|
1,353,653 | $19,925,772 | 2012 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMAX
IMAX CORP
|
Communication Services | 0.72% | 0.58% |
#38
2
Prev: #40
|
2.3 |
—
|
38,462 | 8.1% |
P
S
|
515,554 | $19,596,208 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 0.70% | 0.12% |
#39
74
Prev: #113
|
3.3 |
—
|
3,122,680 | 675.7% |
P
S
|
3,584,820 | $18,999,546 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 0.70% | 0.35% |
#40
25
Prev: #65
|
2.8 |
—
|
631,020 | 46.5% |
P
S
|
1,987,397 | $18,920,019 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.68% | 0.74% |
#41
11
Prev: #30
|
1.3 |
—
|
no change | no change |
P
S
|
1,235,000 | $18,438,550 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RMR
RMR GROUP INC
|
Real Estate | 0.65% | 0.57% |
#42
1
Prev: #41
|
1.3 |
—
|
no change | no change |
P
S
|
1,147,902 | $17,758,044 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RYAM
RAYONIER ADVANC...
|
Basic Materials | 0.65% | 0.35% |
#43
21
Prev: #64
|
0.8 |
—
|
-200,000 | -11.1% |
P
S
|
1,600,000 | $17,712,000 | 2016 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALGN
CALL
ALIGN TECHNOLOG...
|
CALL Option | 0.63% | 0.52% |
#44
3
Prev: #47
|
1.3 |
—
|
no change | no change |
P
S
|
100,000 | $17,143,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GERN
GERON CORP
|
Healthcare | 0.62% | 0.39% |
#45
15
Prev: #60
|
2.7 |
—
|
2,200,000 | 24.4% |
P
S
|
11,225,000 | $16,725,250 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BNTC
BENITEC BIOPHAR...
|
Healthcare | 0.56% | 0.46% |
#46
7
Prev: #53
|
2.7 |
—
|
400,000 | 38.5% |
P
S
|
1,438,371 | $15,318,651 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 0.56% | 0.68% |
#47
16
Prev: #31
|
0.7 |
—
|
-15,998 | -10.4% |
P
S
|
137,237 | $15,281,340 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ITGR
INTEGER HLDGS C...
|
Healthcare | 0.56% | 0.26% |
#48
37
Prev: #85
|
3.2 |
—
|
70,000 | 68.6% |
P
S
|
172,000 | $15,136,000 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KROS
KEROS THERAPEUT...
|
Healthcare | 0.55% | 0.24% |
#49
38
Prev: #87
|
3.2 |
—
|
1,000,000 | 277.5% |
P
S
|
1,360,419 | $15,019,026 | 2020 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JACK
JACK IN THE BOX...
|
Consumer Cyclical | 0.55% | 0.54% |
#50
7
Prev: #43
|
3.2 |
—
|
676,725 | 78.1% |
P
S
|
1,542,715 | $14,918,054 | 2012 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 176 holdings